Ultragenyx Pharmaceutical (RARE) Asset Utilization Ratio (2017 - 2026)

Ultragenyx Pharmaceutical (RARE) has 10 years of Asset Utilization Ratio data on file, last reported at 0.47 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 12.95% year-over-year to 0.47 in Q1 2026; TTM through Mar 2026 was 0.47, a 12.95% increase from a year earlier, with the FY2025 full-year figure at 0.44, up 18.56% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.47, down from 0.49 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for RARE reached as high as 0.5 in Q3 2025 and fell as low as 0.23 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.34 across 5 years, with a median of 0.32 in 2023.
• Across the five-year window, Asset Utilization Ratio decreased 2.61% in 2022 and jumped 52.47% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.23 in 2022, then jumped by 38.48% to 0.32 in 2023, then advanced by 15.79% to 0.37 in 2024, then soared by 34.2% to 0.49 in 2025, then declined by 4.16% to 0.47 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.47 in Q1 2026, 0.49 in Q4 2025, and 0.5 in Q3 2025.